ArticleBMJ public health2026
African Vaccination Week as a catalyst for integrated services and immunisation equity: synthesis of implementation insights from countries in the WHO African Region.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The African Vaccination Week (AVW) is a coordinated initiative designed to raise awareness, strengthen immunisation delivery and promote equity across the WHO African Region. In 2025, AVW coincided with the Immunisation Agenda 2030 midpoint, offering a strategic opportunity to accelerate progress towards reaching zero-dose and under-vaccinated populations. Methods: We conducted a cross-sectional synthesis using aggregated secondary data from country implementation reports submitted to the WHO Regional Office for Africa and insights from postimplementation regional webinars. Data were analysed descriptively to summarise vaccination outputs, integrated service delivery and implementation innovations across countries. Results: 25 countries reported implementing AVW 2025 activities. Approximately 11.5 million children were vaccinated, including 353 133 zero-dose children. Around 100 000 adults received vaccines, primarily tetanus-diphtheria and COVID-19 vaccines. Other interventions delivered along with vaccination included vitamin A supplementation and deworming for over 250 000 children. Several countries leveraged AVW 2025 to introduce vaccines, launch their national immunisation strategy and strengthen integration with primary healthcare services. Conclusions: The AVW 2025 functioned as a regional implementation platform for highlighting immunisation priorities, reaching missed children and supporting integrated primary healthcare delivery across the WHO African Region.Country experiences indicate that AVW achieves the greatest impact when aligned with national programmes and embedded within routine planning processes. Variations in participation and reporting point to the need for stronger advance preparation, sustained engagement with all Member States and adaptable support tailored to country contexts. Positioning AVW as a feasible, low-opportunity-cost mechanism for advocacy, visibility and service delivery alignment can contribute meaningfully to broader immunisation and primary healthcare goals in the Region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.